Cutaneous Reactions after SARS-CoV-2 Vaccination
A nationwide Spanish
cross-sectional study was conducted. Study included patients with cutaneous
reactions within 21 days of any dose of the approved vaccines at the time
of the study.
Published in the British Journal of Dermatology
- Evaluation of 405 cutaneous reactions after
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination
(Pfizer-BioNTech, Moderna, or AstraZeneca) revealed six morphologic
reaction patterns including injection site, urticaria, morbilliform,
papulovesicular, pityriasis rosea-like, and purpuric reactions.
- Injection-site reactions, also known as “COVID
arm,” were the most common reaction pattern and occurred in women 95.4% of
the time. There were also a number of varicella-zoster virus and herpes
virus reactivations. Treatment was required for a cutaneous reaction in
81% of cases.
- Clinicians can utilize this information when
counseling patients regarding SARS-CoV-2 vaccination and providing
management options for cutaneous reactions.
Fig. Cutaneous Reactions (Covid Arm)
Cutaneous reactions after
SARS-CoV-2 vaccination are heterogeneous. Most are mild-to-moderate and
self-limiting, although severe/very severe reactions are reported. Knowledge of
these reactions during mass vaccination may help healthcare professionals and
reassure patients.
There are a number of ways that we can reduce risk and transmission of COVID-19, but vaccination has proven to be quite effective.
Source:
https://pubmed.ncbi.nlm.nih.gov/34254291/
Note: For informational purposes only. Consult your textbook for advising your patients.
Comments
You must login to write comment